Published in Gut on October 01, 2002
MUC1 limits Helicobacter pylori infection both by steric hindrance and by acting as a releasable decoy. PLoS Pathog (2009) 1.69
Helicobacter pylori infection, glandular atrophy and intestinal metaplasia in superficial gastritis, gastric erosion, erosive gastritis, gastric ulcer and early gastric cancer. World J Gastroenterol (2005) 1.19
Diet, microbial virulence, and Helicobacter pylori-induced gastric cancer. Gut Microbes (2013) 1.13
Prevalence of vacA, cagA and babA2 genes in Cuban Helicobacter pylori isolates. World J Gastroenterol (2009) 1.11
Roles of Helicobacter pylori BabA in gastroduodenal pathogenesis. World J Gastroenterol (2008) 1.11
Helicobacter pylori BabA expression, gastric mucosal injury, and clinical outcome. Clin Gastroenterol Hepatol (2006) 1.08
Effect of peroxisome proliferator activated receptor gamma ligands on growth and gene expression profiles of gastric cancer cells. Gut (2004) 0.98
Immune response and the tumor microenvironment: how they communicate to regulate gastric cancer. Gut Liver (2014) 0.88
Helicobacter pylori Diversity and Gastric Cancer Risk. MBio (2016) 0.88
Clinical relevance of Helicobacter pylori babA2 and babA2/B in Costa Rica and Japan. World J Gastroenterol (2010) 0.87
Virulence attributes of Helicobacter pylori isolates & their association with gastroduodenal disease. Indian J Med Res (2011) 0.86
Inflammatory cytokine gene polymorphisms increase the risk of atrophic gastritis and intestinal metaplasia. World J Gastroenterol (2010) 0.82
Prevalence of virulence-associated genotypes of Helicobacter pylori and correlation with severity of gastric pathology in patients from western Sicily, Italy. Eur J Clin Microbiol Infect Dis (2008) 0.81
Helicobacter pylori infection is associated with a high incidence of intestinal metaplasia in the gastric mucosa of patients at inner-city hospitals in New York. Dig Dis Sci (2006) 0.78
Different cell kinetic changes in rat stomach cancer after treatment with celecoxib or indomethacin: implications on chemoprevention. World J Gastroenterol (2005) 0.77
A unique feature of iron loss via close adhesion of Helicobacter pylori to host erythrocytes. PLoS One (2012) 0.76
Impact of Helicobacter pylori on the healing process of the gastric barrier. World J Gastroenterol (2016) 0.76
Atomic force microscopy measurements reveal multiple bonds between Helicobacter pylori blood group antigen binding adhesin and Lewis b ligand. J R Soc Interface (2014) 0.76
Phosphorylation by mTORC1 stablizes Skp2 and regulates its oncogenic function in gastric cancer. Mol Cancer (2017) 0.75
Alteration of sister chromatid exchange frequencies in gastric cancer and chronic atrophic gastritis patients with and without H. pylori infection. World J Gastroenterol (2008) 0.75
Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol (1996) 21.37
Human gastric carcinogenesis: a multistep and multifactorial process--First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res (1992) 12.77
Mosaicism in vacuolating cytotoxin alleles of Helicobacter pylori. Association of specific vacA types with cytotoxin production and peptic ulceration. J Biol Chem (1995) 12.61
Molecular characterization of the 128-kDa immunodominant antigen of Helicobacter pylori associated with cytotoxicity and duodenal ulcer. Proc Natl Acad Sci U S A (1993) 11.85
Translocation of Helicobacter pylori CagA into gastric epithelial cells by type IV secretion. Science (2000) 7.99
Attachment of Helicobacter pylori to human gastric epithelium mediated by blood group antigens. Science (1993) 7.86
Helicobacter pylori adhesin binding fucosylated histo-blood group antigens revealed by retagging. Science (1998) 6.99
Shigella flexneri induces apoptosis in infected macrophages. Nature (1992) 6.26
Modelling cost-effectiveness of Helicobacter pylori screening to prevent gastric cancer: a mandate for clinical trials. Lancet (1996) 5.03
Recombination and clonal groupings within Helicobacter pylori from different geographical regions. Mol Microbiol (1999) 4.72
Risk for gastric cancer in people with CagA positive or CagA negative Helicobacter pylori infection. Gut (1997) 4.70
Clinical relevance of the Helicobacter pylori gene for blood-group antigen-binding adhesin. Proc Natl Acad Sci U S A (1999) 4.55
Relationship between Helicobacter pylori iceA, cagA, and vacA status and clinical outcome: studies in four different countries. J Clin Microbiol (1999) 4.13
Population genetic analysis of Helicobacter pylori by multilocus enzyme electrophoresis: extensive allelic diversity and recombinational population structure. J Bacteriol (1996) 3.32
Atrophy and intestinal metaplasia one year after cure of H. pylori infection: a prospective, randomized study. Gastroenterology (2000) 2.99
Helicobacter pylori cagA+ strains and dissociation of gastric epithelial cell proliferation from apoptosis. J Natl Cancer Inst (1997) 2.95
Helicobacter pylori and gastric carcinogenesis. Am J Surg Pathol (1995) 2.64
Induction of gastric epithelial apoptosis by Helicobacter pylori. Gut (1996) 2.58
Inducible nitric oxide synthase, nitrotyrosine, and apoptosis in Helicobacter pylori gastritis: effect of antibiotics and antioxidants. Cancer Res (1996) 2.56
Increase in proliferation and apoptosis of gastric epithelial cells early in the natural history of Helicobacter pylori infection. Am J Pathol (1997) 1.74
Key importance of the Helicobacter pylori adherence factor blood group antigen binding adhesin during chronic gastric inflammation. Cancer Res (2001) 1.67
Clinical relevance of the babA2 genotype of Helicobacter pylori in Japanese clinical isolates. J Clin Microbiol (2001) 1.38
Helicobacter pylori: molecular basis for host recognition and bacterial adherence. Trends Microbiol (1994) 1.26
Assessment of proliferation of squamous, Barrett's and gastric mucosa in patients with columnar lined Barrett's oesophagus. Gut (1992) 1.20
Relationship of Helicobacter pylori CagA status to gastric cell proliferation and apoptosis. Dig Dis Sci (1999) 1.12
The role of the HLA-DQA1 gene in resistance to atrophic gastritis and gastric adenocarcinoma induced by Helicobacter pylori infection. Cancer (1998) 1.11
Helicobacter pylori and cell proliferation of the gastric mucosa: possible implications for gastric carcinogenesis. Am J Gastroenterol (1996) 1.11
Helicobacter pylori vacA, iceA, and cagA status and pattern of gastritis in patients with malignant and benign gastroduodenal disease. Am J Gastroenterol (2001) 1.10
Effect of eradication of Helicobacter pylori on gastric epithelial cell proliferation. Aliment Pharmacol Ther (1994) 1.07
Gastric cancer and premalignant lesions in atrophic gastritis: a controlled trial on the effect of supplementation with alpha-tocopherol and beta-carotene. The Helsinki Gastritis Study Group. Scand J Gastroenterol (1998) 1.06
Review article: Cellular markers in the gastric precancerous process. Aliment Pharmacol Ther (1998) 0.96
Evaluation of a selective transport medium for gastric biopsy specimens to be cultured for Helicobacter pylori. J Clin Microbiol (1998) 0.96
Interaction of Helicobacter pylori eradication and non-steroidal anti-inflammatory drugs on gastric epithelial apoptosis and proliferation: implications on ulcerogenesis. Aliment Pharmacol Ther (2000) 0.93
Gastric mucosal inflammation and epithelial cell turnover are associated with gastric cancer in patients with Helicobacter pylori infection. J Clin Pathol (2000) 0.92
Helicobacter pylori infection does not increase gastric antrum mucosal cell proliferation. Am J Gastroenterol (1995) 0.85
A major outbreak of severe acute respiratory syndrome in Hong Kong. N Engl J Med (2003) 21.55
Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening. Gut (2009) 8.98
Increasing incidence of colorectal cancer in Asia: implications for screening. Lancet Oncol (2005) 5.13
Tropism of avian influenza A (H5N1) in the upper and lower respiratory tract. Nat Med (2007) 3.75
Randomised trial of eradication of Helicobacter pylori before non-steroidal anti-inflammatory drug therapy to prevent peptic ulcers. Lancet (1997) 3.67
Early clinical experience of the safety and effectiveness of Hemospray in achieving hemostasis in patients with acute peptic ulcer bleeding. Endoscopy (2011) 3.39
Capsule endoscopy in acute upper gastrointestinal hemorrhage: a prospective cohort study. Endoscopy (2012) 3.28
Asia Pacific consensus recommendations for colorectal cancer screening. Gut (2008) 3.19
Preventing recurrent upper gastrointestinal bleeding in patients with Helicobacter pylori infection who are taking low-dose aspirin or naproxen. N Engl J Med (2001) 3.02
Treatment of severe acute respiratory syndrome with convalescent plasma. Hong Kong Med J (2003) 3.01
Atrophy and intestinal metaplasia one year after cure of H. pylori infection: a prospective, randomized study. Gastroenterology (2000) 2.99
Peptic-ulcer disease. Lancet (2002) 2.92
Dyspepsia is strongly associated with major depression and generalised anxiety disorder - a community study. Aliment Pharmacol Ther (2012) 2.80
Eradication of Helicobacter pylori and risk of peptic ulcers in patients starting long-term treatment with non-steroidal anti-inflammatory drugs: a randomised trial. Lancet (2002) 2.52
Comparison of EUS and ERCP in the investigation with suspected biliary obstruction caused by choledocholithiasis: a randomized study. Gastrointest Endosc (2007) 2.50
MicroRNA dysregulation in gastric cancer: a new player enters the game. Oncogene (2010) 2.23
Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome. Clin Exp Immunol (2004) 2.21
Haematological manifestations in patients with severe acute respiratory syndrome: retrospective analysis. BMJ (2003) 2.20
High frequency of promoter hypermethylation of RASSF1A in nasopharyngeal carcinoma. Cancer Res (2001) 2.07
The use of prophylactic gastroprotective therapy in patients with nonsteroidal anti-inflammatory drug- and aspirin-associated ulcer bleeding: a cross-sectional study. Aliment Pharmacol Ther (2013) 2.02
MicroRNA-143 targets DNA methyltransferases 3A in colorectal cancer. Br J Cancer (2009) 1.88
Outcomes of adults hospitalised with severe influenza. Thorax (2010) 1.80
Microbiology of odontogenic bacteremia: beyond endocarditis. Clin Microbiol Rev (2009) 1.71
Factors predicting progression of gastric intestinal metaplasia: results of a randomised trial on Helicobacter pylori eradication. Gut (2004) 1.68
Pore-forming properties of the major 53-kilodalton surface antigen from the outer sheath of Treponema denticola. Infect Immun (1993) 1.66
The natural history of immunoglobulin a nephropathy among patients with hematuria and minimal proteinuria. Am J Med (2001) 1.62
The autophagic paradox in cancer therapy. Oncogene (2011) 1.61
Characterization, cloning, and binding properties of the major 53-kilodalton Treponema denticola surface antigen. Infect Immun (1992) 1.61
Warburg effect revisited: an epigenetic link between glycolysis and gastric carcinogenesis. Oncogene (2009) 1.58
Hypercytokinemia and hyperactivation of phospho-p38 mitogen-activated protein kinase in severe human influenza A virus infection. Clin Infect Dis (2007) 1.57
NOD2/CARD15 gene polymorphisms and Crohn's disease in the Chinese population. Aliment Pharmacol Ther (2003) 1.54
Intrarectal administration of mCRAMP-encoding plasmid reverses exacerbated colitis in Cnlp(-/-) mice. Gene Ther (2012) 1.53
Risk factors associated with a decrease ≥2 g/dL in haemoglobin and/or ≥10% haematocrit in osteoarthritis patients taking celecoxib or a nonselective NSAID plus a PPI in a large randomised controlled trial (CONDOR). Aliment Pharmacol Ther (2012) 1.51
Cyclooxygenase-2 expression in Helicobacter pylori-associated premalignant and malignant gastric lesions. Am J Pathol (2000) 1.50
A frequent activated smoothened mutation in sporadic basal cell carcinomas. Oncogene (1999) 1.49
Prediction of therapeutic failure after adrenaline injection plus heater probe treatment in patients with bleeding peptic ulcer. Gut (2002) 1.49
Diabetic patients with IgA nephropathy and diabetic glomerulosclerosis. Mod Pathol (1993) 1.46
Review article: the role of non-biological drugs in refractory inflammatory bowel disease. Aliment Pharmacol Ther (2010) 1.45
Concomitant irritable bowel syndrome is associated with failure of step-down on-demand proton pump inhibitor treatment in patients with gastro-esophageal reflux disease. Neurogastroenterol Motil (2010) 1.45
Oral health status and treatment need of 11-13-year-old urban children in Tibet, China. Community Dent Health (2000) 1.44
Cytopathic effects of the major surface protein and the chymotrypsinlike protease of Treponema denticola. Infect Immun (1998) 1.43
Predicting mortality in patients with bleeding peptic ulcers after therapeutic endoscopy. Clin Gastroenterol Hepatol (2008) 1.40
Ultrastructural calcification of glomerular immune complexes. Mod Pathol (1996) 1.39
Concurrent hypermethylation of multiple tumor-related genes in gastric carcinoma and adjacent normal tissues. Cancer (2001) 1.38
The clinical efficacy of neoadjuvant chemotherapy in squamous esophageal cancer: a prospective nonrandomized study of pulse and continuous-infusion regimens with Cisplatin and 5-Fluorouracil. Ann Surg Oncol (2002) 1.38
Review article: intestinal metaplasia and gastric carcinogenesis. Aliment Pharmacol Ther (2002) 1.38
Eradication of Helicobacter pylori prevents recurrence of ulcer after simple closure of duodenal ulcer perforation: randomized controlled trial. Ann Surg (2000) 1.37
Cytopathic effects of Treponema denticola chymotrypsin-like proteinase on migrating and stratified epithelial cells. Infect Immun (1995) 1.37
microRNA-7 is a novel inhibitor of YY1 contributing to colorectal tumorigenesis. Oncogene (2012) 1.36
The major surface protein complex of Treponema denticola depolarizes and induces ion channels in HeLa cell membranes. Infect Immun (1996) 1.36
Shorter durations and lower doses of peginterferon alfa-2a are associated with inferior hepatitis B e antigen seroconversion rates in hepatitis B virus genotypes B or C. Hepatology (2011) 1.35
Frequent epigenetic inactivation of secreted frizzled-related protein 2 (SFRP2) by promoter methylation in human gastric cancer. Br J Cancer (2007) 1.33
Increased placental apoptosis in pregnancies complicated by preeclampsia. Am J Obstet Gynecol (2001) 1.31
Agreements among traditional Chinese medicine practitioners in the diagnosis and treatment of irritable bowel syndrome. Aliment Pharmacol Ther (2004) 1.30
Accuracy of endoscopic ultrasonography in diagnosing ascites and predicting peritoneal metastases in gastric cancer patients. Gut (2005) 1.28
Diagnosis of gastroesophageal varices and portal collateral venous abnormalities by endosonography in cirrhotic patients. Endoscopy (2002) 1.25
Effect of Helicobacter pylori eradication on oesophageal acid exposure in patients with reflux oesophagitis. Aliment Pharmacol Ther (2002) 1.23
Association of interleukin 1B gene polymorphism and gastric cancers in high and low prevalence regions in China. Gut (2003) 1.22
Diagnostic accuracy of faecal immunochemical test for screening individuals with a family history of colorectal cancer. Aliment Pharmacol Ther (2013) 1.20
MicroRNA dysregulation in colorectal cancer: a clinical perspective. Br J Cancer (2011) 1.20
Conservation of msp, the gene encoding the major outer membrane protein of oral Treponema spp. J Bacteriol (1997) 1.18
Epigenetic inactivation of T-box transcription factor 5, a novel tumor suppressor gene, is associated with colon cancer. Oncogene (2010) 1.17
High frequency of chromosome 3p deletion in histologically normal nasopharyngeal epithelia from southern Chinese. Cancer Res (2000) 1.17
Antiviral treatment for patients hospitalized with severe influenza infection may affect clinical outcomes. Clin Infect Dis (2008) 1.17
Epigenetic disruption of interferon-gamma response through silencing the tumor suppressor interferon regulatory factor 8 in nasopharyngeal, esophageal and multiple other carcinomas. Oncogene (2008) 1.16
Constitutional activation of IL-6-mediated JAK/STAT pathway through hypermethylation of SOCS-1 in human gastric cancer cell line. Br J Cancer (2004) 1.15
Concurrent hypermethylation of multiple genes is associated with grade of oligodendroglial tumors. J Neuropathol Exp Neurol (2001) 1.14
Kaposiform hemangioendothelioma: five patients with cutaneous lesion and long follow-up. Mod Pathol (2001) 1.14
High resolution allelotype of microdissected primary nasopharyngeal carcinoma. Cancer Res (2000) 1.14
Epidemiology of irritable bowel syndrome in Chinese. Dig Dis Sci (2002) 1.12
Improved colonoscopy success rate with a distally attached mucosectomy cap. Endoscopy (2006) 1.12